Clinical Trials
3 trialsNCT06392009 2026-04-01
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
GRIN Therapeutics, Inc.
Phase 1/2 Active not recruiting
NCT07287202 2025-12-23
Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)
Sovargen
Phase 1/2 Not yet recruiting
NCT05364021 2024-11-08
PACIFIC
Longboard Pharmaceuticals
Phase 1/2 Completed